Project Grant R01DA066715
Award Date 7/1/26
Completion Date 4/30/31
Dollars Obligated $797K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Roxbury, MA 02118, USA
Similar Awards
- Federal Grant Award Summary Boston Medical Center Corporation received a $2.67 million Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning May 1, 2026 and concluding April 30, 2030. The award funds The LINK Intervention, a system-wide strategy designed to optimize medications for opioid use disorder (MOUD) and pre-exposure prophylaxis for HIV (PrEP) utilization within health systems. The initiative addresses the...
- Federal Grant Award Summary Boston Medical Center Corporation received a $356,630 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded September 1, 2025, with completion scheduled for August 31, 2027. The grant supports immune profiling research investigating how drug abuse impacts antibody responses in people living with HIV (PLWH), particularly among people who use substances and live with HIV (PWUSH). The...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Massachusetts General Hospital $476,808 under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and validate precision risk models for predicting opioid overdose deaths among individuals experiencing homelessness. The project, which commenced May 15, 2026 and concludes April 30, 2028, delivers two primary products: (1) predictive models for opioid overdose mortality and all-cause mortality...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $197,640 Project Grant to Massachusetts General Hospital on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). This four-year research initiative (completion date: February 28, 2030) focuses on evaluating the clinical impact and cost-effectiveness of integrating infectious disease (ID) care into rapid-access substance use bridge clinics. The research will address the syndemic of...
- Federal Project Grant Award Summary Baystate Medical Center, Inc. received a $187,023 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), effective September 1, 2025, through August 31, 2030. This mentored research career development award leverages Massachusetts' statewide Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program as a natural experiment to conduct a mixed-methods study examining the...
- Federal Grant Award Summary Boston Medical Center Corporation received a $231,600 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 15, 2025, to support the annual Academic Consortium of Criminal Justice Health (ACCJH) Conference through May 31, 2030. The grant funds scholarships for early-stage investigators and individuals with lived experience of incarceration to attend the two-day conference,...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Pennsylvania a $1.59 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a rigorous evaluation of Hospital-to-Housing (H2H), a medically supported transitional housing intervention for individuals experiencing homelessness with opioid use disorder (OUD) following hospitalization. The award, issued August 15, 2025, with completion targeted for May...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded McLean Hospital a $736,811 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a longitudinal cohort study of opioid use disorder. The study, initiated June 1, 2026, and extending through March 31, 2031, will follow 550 adults with opioid use disorder recruited across multiple U.S. sites to characterize the long-term course of the disorder against the evolving landscape of...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Trustees of Boston University a $193,751 Project Grant effective May 1, 2026, through April 30, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). This Career Development Award supports the applicant's development as an independent substance use disorder (SUD) services researcher through a rigorous training and research plan. The primary deliverables include: (1) examination of quality...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston University Medical Campus a $193,180 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning March 15, 2026, and concluding February 28, 2031. This K01 Career Development Award provides mentorship and training to support Dr. Auty's development as an independent investigator examining how Medicaid Managed Care (MMC) networks and policies influence access to care and health...